These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 680625

  • 1. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F.
    Fortschr Med; 1978 Aug 24; 96(32):1619-21. PubMed ID: 680625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
    Matzkies F, Berg G.
    Dtsch Med Wochenschr; 1976 Oct 22; 101(43):1568-70. PubMed ID: 991731
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP.
    Med Klin; 1977 Apr 15; 72(15):664-8. PubMed ID: 857138
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F.
    Med Klin (Munich); 1992 Sep 15; 87(9):460-2. PubMed ID: 1406482
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H.
    Z Gesamte Inn Med; 1990 Dec 01; 45(23):719-20. PubMed ID: 2102029
    [Abstract] [Full Text] [Related]

  • 13. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
    Masbernard A, Giudicelli CP.
    S Afr Med J; 1981 May 09; 59(20):701-6. PubMed ID: 7221794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR, Dreykluft HR, Leonhardt H.
    Fortschr Med; 1979 Jul 19; 97(27):1212-4. PubMed ID: 457017
    [Abstract] [Full Text] [Related]

  • 17. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M, Ikegami M, Ishii T, Nishioka T, Uemura T, Kunikata S, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1990 Aug 19; 36(8):893-6. PubMed ID: 2239590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
    Bach D, Hesse A, Strenge A, Vahlensieck W.
    Fortschr Med; 1980 Nov 27; 98(44):1752-5. PubMed ID: 7461567
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.